Effects of Proxelan Somministration in Patients With Chronic Prostatitis

University of Pisa30 enrolled

Overview

The purpose of the study is to determinate the antinflammatory effects of the Proxelan on a cohort of patients affected by prostatitis'like symptoms and clinical evidence of abacterical prostatistis, trough a significative improvements of pain symptoms according to the NIH-CPSI questionnaire items, spermatozoa motility/concentration variations and the semen cytokines level decrease.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Chronic Prostatitis Chronic Prostatitis With Chronic Pelvic Pain Syndrome Premature Ejaculation

Interventions

ProxelanDRUG

Administration of one suppository of proxelan once a day for 30 days

Eligibility

Sex: MALEMin age: 18 YearsMax age: 50 Years

Medical Language ↔ Plain English

Inclusion Criteria: \- prostatitis like symptoms for at least three months Exclusion Criteria: * significant post-voidal residual volume * Meares and Stamey test suggestive for bacterial infection * neoplasms, * urinary stones, * antibiotic therapy in the previous three months, * irritable bowel syndrome, * previous radiotherapic or chemiotherapic treatment, * urethral stenosis, * neurogenic bladder * previous prostatic surgery

Locations (1)

AOUP Ospedale cisanello

Pisa, Tuscany, Italy

RECRUITING

Outcomes

Primary Outcomes

National Institutes of Health - Chronic Prostatitis Symptom (NIH-CPS) questionnaires score

Evaluation of pain symptoms trough NIH-CPS questionnaires' pain items (0-6). Values from 0 to 3 normal/slight symptoms; Values from 3 to 6 moderate symptoms; Values over 6 severe symptoms.

Time frame: 30 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.